Events

Members of the Institute of Neurogenetics participate in the Global Parkinson’s Genetics Program (GP2) Annual In-Person Meeting in Madrid on September 13 and 14, 2022 and present recent progress from the Monogenic Network of GP2.

Events /

Members of the Institute of Neurogenetics participate in the Global Parkinson’s Genetics Program (GP2) Annual In-Person Meeting in Madrid on September 13 and 14, 2022 and present recent progress from the Monogenic Network of GP2. Read More »

The Institute of Neurogenetics opened its doors to the 9th-grad students from the “MINT for girls” program.

Events /

On March 2nd, 2022, the Institute of Neurogenetics opened its doors to the 9th-grad students from the “MINT for girls” program at the Geschwister-Prenski-Schule. The Campus Day was organized by the “Hanse Innovation Campus Lübeck.” “WINnovation – Women in INnovation” enabled these students to take a closer look into the field of Neurogenetics, allowing them

The Institute of Neurogenetics opened its doors to the 9th-grad students from the “MINT for girls” program. Read More »

Lecture by Prof. Dr. Rifat Hamoudi on his paper: “Enriched transcriptome analysis of laser capture microdissected populations of single cells to investigate intracellular heterogeneity in immunostained FFPE sections”.

Events /

Dr. Rifat Hamoudi, Ph.D, C.Eng, C.Sci is a Professor in Molecular, Cellular and Computational Medicine in the College of Medicine at the University of Sharjah, UAE. He is also an honorary faculty at the Division of Surgery & Interventional Science, UCL, UK. He is a multi and inter-disciplinary researcher with deep background and work experience

Lecture by Prof. Dr. Rifat Hamoudi on his paper: “Enriched transcriptome analysis of laser capture microdissected populations of single cells to investigate intracellular heterogeneity in immunostained FFPE sections”. Read More »

Listen to our colleague Melissa Vos on the “Scientist Speaks Podcast” speaking about the impact on lipids as a slippery path towards Parkinson’s Disease

Events /

This podcast highlights our most recent work published in PNAS that uncovered the role of ceramide accumulation in PINK1-dependent Parkinson’s disease. We found that ceramide accumulates to induce mitophagy and impair ß-oxidation. Reduction of mitophagy or elevation of ß-oxidatoin may be a novel therapeutic target in the treatment of Parkinson’s disease. Listen to the podcast

Listen to our colleague Melissa Vos on the “Scientist Speaks Podcast” speaking about the impact on lipids as a slippery path towards Parkinson’s Disease Read More »